GATA3 and breast carcinoma: GATA‐3 labeling has been demonstrated to be highly specific for identifying the metastasis of TNBC breast carcinomas in distant sites (e.g., lung and brain) (Sangoi, Shrestha, Yang, Mego, & Beck, 2016).